Home - Ionis Pharmaceuticals

News

December 6, 2018

Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 DataMore »

November 27, 2018

First-in-class therapies using advanced antisense chemistries highlighted at 2018 American Society of Hematology Annual MeetingMore »

November 13, 2018

Ionis Pharmaceuticals to Present at Jefferies 2018 London Healthcare ConferenceMore »

November 12, 2018

Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific SessionsMore »

Events

12-12-2018

BMO Prescription for Success Healthcare Conference

Latest Updates

The award is in recognition @ionispharma's commitment to employee health and well-being by promoting #WorkLifeBalance. If you want to learn more about working at @ionispharma, check out this profile of our #LifeInAction Active Ambassador Victor Tapia.

https://t.co/FM3CbhpcCw

Congratulations to @ionispharma for receiving the 2018 North County Excellence In Economic Development Award! Wayne Sanders is on hand to accept. 👏 👏 👏 #northcountyprosperity @SDNorthEDC

Clinical Trials

We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »